Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v1-EN
Language English English
Date Updated 2022-10-18 2022-06-30
Drug Identification Number 02355515 02355515
Brand name TEVA-MONTELUKAST TEVA-MONTELUKAST
Common or Proper name TEVA-MONTELUKAST 5MG CHEW TABS TEVA-MONTELUKAST 5MG CHEW TABS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients MONTELUKAST MONTELUKAST
Strength(s) 5MG 5MG
Dosage form(s) TABLET (CHEWABLE) TABLET (CHEWABLE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 30
ATC code R03DC R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-06-30 2022-06-30
Estimated end date 2022-10-20 2022-08-10
Actual end date 2022-10-17
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments